| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $141.2M | -23.4% | -10.4% |
| SG&A Expense | $28.2M | +3.2% | +37.2% |
| Operating Income | -$169.4M | +20.0% | +4.9% |
| Pre-tax Income | -$173.2M | +12.5% | -8.0% |
| Income Tax | $221K | -15.3% | +474.6% |
| Net Income | -$173.4M | +12.5% | -8.2% |
| EPS (Basic) | -$1.64 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $184.8M | +11.5% | +119.0% |
| Short-term Investments | $75.4M | -68.5% | -74.4% |
| Current Assets | $323.6M | -31.8% | -26.5% |
| Total Assets | $409.1M | -25.7% | -19.9% |
| Current Liabilities | $113.0M | -9.1% | -25.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$478.8M | — | — |
| Capital Expenditures | $707K | — | — |
| Investing Cash Flow | $314.3M | — | — |
| Financing Cash Flow | $250.3M | — | — |
| Free Cash Flow | -$479.5M | — | — |
| +15.5% |
| +3.5% |
| EPS (Diluted) | -$1.64 | +15.5% | +3.5% |
| $426.3M |
| +2.5% |
| +119.1% |
| Stockholders' Equity | -$17.2M | -112.8% | -105.4% |